DeGroff C G, Silka M J
Clinical Care Center for Congenital Heart Disease, Oregon Health Sciences University, Portland 97201-3098.
J Pediatr. 1994 Nov;125(5 Pt 1):822-3. doi: 10.1016/s0022-3476(94)70085-0.
We describe a 13-year-old patient with asthma in whom severe bronchospasm developed immediately after the intravenous administration of 12 mg of adenosine. The risk of bronchospasm in patients with reactive airway disease may favor the use of alternative methods for the termination of supraventricular tachycardia.
我们描述了一名13岁的哮喘患者,在静脉注射12毫克腺苷后立即发生了严重的支气管痉挛。反应性气道疾病患者发生支气管痉挛的风险可能支持采用其他方法来终止室上性心动过速。